Vendor directory

Aclaris Therapeutics

Aclaris Therapeutics describes itself as a biopharmaceutical company working on immuno-inflammatory conditions. Its site links to a drug development pipeline and clinical trials. A recent site update names modzatinib (ATI-2138) in its clinical development work.

Category Dermatology therapeutics
Website [https://aclaristx.com][vendor-site]

Description based on the company's own website. Source: [https://aclaristx.com][vendor-site].

Listings are not endorsements. Vendors can request a correction or an enhanced listing.

[vendor-site]: https://aclaristx.com

Other vendors in Dermatology therapeutics

Bausch Health Bristol Myers Squibb Incyte Verrica Pharmaceuticals

Backed by Richard C. Wilson and Family Office Club, the largest investor club in the world by media reach

$1B+In deals closed between members
17MRegistered members across our networking groups
19MSocial media followers
340+Events hosted since 2007
16In-person events a year
50AI tools built on what works with family offices and investors

Family Office Club network figures. They describe the organization and its members, not a promise of investment or transaction results.

Aclaris Therapeutics

Related resources

Other vendors in Dermatology therapeutics